Safety Alerts

MHRA Class 2 Medicines Recall: Mynzepli 40 mg/mL solution for injection in pre-filled syringe (Advanz Pharma Limited)

Published
Source
PSNC Dispensing & Supply News
Imported
29 Oct 2026

MHRA Class 2 Medicines Recall: Mynzepli 40 mg/mL solution for injection in pre-filled syringe (Advanz Pharma Limited). Drug alert number: EL(26)A/44 Date issued: 29 October 2026 Advanz Pharma Limited are recalling specified batches of Mynzepli 40 mg/mL solution for injection in pre-filled syringe as a precautionary measure. DMRC reference number: DMRC-41252013 Company name: Advanz Pharma Limited [...]

The post MHRA Class 2 Medicines Recall: Mynzepli 40 mg/mL solution for injection in pre-filled syringe (Advanz Pharma Limited) appeared first on Community Pharmacy England.

View original alert (opens in a new tab)

Important: This alert is gathered automatically for information only. Always refer to the original source and follow your practice’s own clinical governance procedures.

The weekly digest lists every alert published in a week, grouped by source. View the weekly digest

Back to Safety Alerts